• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值对早期卵巢透明细胞癌的预后价值。

Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma.

机构信息

Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

J Gynecol Oncol. 2019 Nov;30(6):e85. doi: 10.3802/jgo.2019.30.e85.

DOI:10.3802/jgo.2019.30.e85
PMID:31576683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6779610/
Abstract

OBJECTIVES

There is increasing evidence that systemic inflammatory response (SIR) markers are prognostic factors for various types of cancers. This is the first study to evaluate the usefulness of SIR markers for the prognosis of early-stage ovarian clear-cell carcinoma (OCCC).

METHODS

We retrospectively investigated 83 patients diagnosed with stage I-II OCCC who underwent surgery between 2005 and 2017. Initially, receiver operating characteristic curve analysis for overall survival (OS) was used to determine optimal cut-off values for neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR). Patients were stratified into 2 groups by the cut-off values (NLR=3.26, PLR=160). Univariate and multivariate analyses were performed to elucidate the significance of SIR markers as prognostic factors.

RESULTS

In the median follow-up period of 64.1 months, 16 patients experienced recurrence, and nine patients died. The Kaplan-Meier curve showed that OS of the NLR-low group was significantly longer than the NLR-high group (p=0.021). There was no significant difference in progression-free survival between the 2 groups (p=0.668), but the post-recurrence survival of the NLR-low group was significantly longer than the NLR-high group (p=0.019). Furthermore, multivariate analysis showed that increase in NLR is a significant independent prognostic factor for poor prognosis (hazard ratio=7.437, p=0.017). There was no significant difference between PLR-low and PLR-high group.

CONCLUSION

Results suggest that NLR can be a significant independent prognostic factor for early-stage OCCC.

摘要

目的

越来越多的证据表明全身炎症反应(SIR)标志物是各种癌症的预后因素。这是第一项评估 SIR 标志物对早期卵巢透明细胞癌(OCCC)预后价值的研究。

方法

我们回顾性调查了 2005 年至 2017 年间接受手术治疗的 83 例 I-II 期 OCCC 患者。首先,采用受试者工作特征曲线分析对总生存期(OS)进行分析,以确定中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)的最佳截断值。根据截断值(NLR=3.26,PLR=160)将患者分为 2 组。采用单因素和多因素分析阐明 SIR 标志物作为预后因素的意义。

结果

在中位随访 64.1 个月期间,16 例患者复发,9 例患者死亡。Kaplan-Meier 曲线显示 NLR 低组的 OS 明显长于 NLR 高组(p=0.021)。两组间无进展生存期无显著差异(p=0.668),但 NLR 低组的复发后生存时间明显长于 NLR 高组(p=0.019)。此外,多因素分析显示 NLR 升高是预后不良的独立显著预后因素(危险比=7.437,p=0.017)。PLR 低值组与 PLR 高值组之间无显著差异。

结论

结果表明,NLR 可能是早期 OCCC 的一个重要独立预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f38/6779610/adcc7b65788d/jgo-30-e85-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f38/6779610/84d6831e21e9/jgo-30-e85-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f38/6779610/929de8992cbd/jgo-30-e85-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f38/6779610/adcc7b65788d/jgo-30-e85-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f38/6779610/84d6831e21e9/jgo-30-e85-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f38/6779610/929de8992cbd/jgo-30-e85-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f38/6779610/adcc7b65788d/jgo-30-e85-g003.jpg

相似文献

1
Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma.中性粒细胞与淋巴细胞比值对早期卵巢透明细胞癌的预后价值。
J Gynecol Oncol. 2019 Nov;30(6):e85. doi: 10.3802/jgo.2019.30.e85.
2
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值可预测接受铂类化疗的上皮性卵巢癌患者的化疗反应及预后。
Cancer Biomark. 2016 Jun 7;17(1):33-40. doi: 10.3233/CBM-160614.
3
Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.系统免疫炎症指数、中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值可预测纳武利尤单抗治疗转移性非小细胞肺癌患者的临床结局。
J Clin Lab Anal. 2019 Oct;33(8):e22964. doi: 10.1002/jcla.22964. Epub 2019 Jul 8.
4
Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.血小板/淋巴细胞比值和中性粒细胞/淋巴细胞比值在可切除胃癌患者早期诊断及预后预测中的应用
Cancer Biomark. 2015;15(6):899-907. doi: 10.3233/CBM-150534.
5
The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.术前控制营养状况(CONUT)评分是可切除胸段食管鳞状细胞癌患者的独立预后因素:一项回顾性研究结果
BMC Cancer. 2016 Sep 6;16(1):722. doi: 10.1186/s12885-016-2696-0.
6
Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值和血小板与淋巴细胞比值在第 +100 天能否作为自体移植多发性骨髓瘤患者的预后标志物?
Clin Transplant. 2018 Sep;32(9):e13359. doi: 10.1111/ctr.13359. Epub 2018 Aug 26.
7
Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.术前中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值和单核细胞与淋巴细胞比值的联合:子宫内膜癌的一个优越预后因素。
BMC Cancer. 2020 May 24;20(1):464. doi: 10.1186/s12885-020-06953-8.
8
Elevated preoperative platelet to lymphocyte ratio associated with decreased survival of women with ovarian clear cell carcinoma.术前血小板与淋巴细胞比值升高与卵巢透明细胞癌女性患者生存率降低相关。
Asian Pac J Cancer Prev. 2014;15(24):10831-6. doi: 10.7314/apjcp.2014.15.24.10831.
9
Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.基于预处理炎症的标志物预测射频消融治疗后早期肝细胞癌患者的生存结局。
Sci Rep. 2018 Nov 9;8(1):16611. doi: 10.1038/s41598-018-34543-z.
10
Investigating Preoperative Hematologic Markers for Prediction of Ovarian Cancer Surgical Outcome.研究术前血液学标志物以预测卵巢癌手术结果。
Asian Pac J Cancer Prev. 2016;17(3):1445-8. doi: 10.7314/apjcp.2016.17.3.1445.

引用本文的文献

1
Enhanced prognostic stratification in early-stage epithelial ovarian cancer: multi-histological analysis of neutrophil-to-lymphocyte ratio with particular emphasis on clear cell histology.早期上皮性卵巢癌的预后分层增强:中性粒细胞与淋巴细胞比值的多组织学分析,特别关注透明细胞组织学
Am J Cancer Res. 2025 Aug 25;15(8):3632-3644. doi: 10.62347/BETA4769. eCollection 2025.
2
Development and Validation of Predictive Risk Scores for Ovarian Clear Cell Carcinoma: A Penalized Regression Model.卵巢透明细胞癌预测风险评分的开发与验证:一种惩罚回归模型
Cancer Med. 2025 Aug;14(15):e71118. doi: 10.1002/cam4.71118.
3
The Clinical Value of Systemic Immune Inflammatory Index in Predicting the Prognosis of Patients with Bloodstream Infection.

本文引用的文献

1
Role of systemic inflammatory response markers in urological malignancy.全身炎症反应标志物在泌尿系统恶性肿瘤中的作用。
Int J Urol. 2019 Jan;26(1):31-47. doi: 10.1111/iju.13801. Epub 2018 Sep 25.
2
Neutrophil to lymphocyte ratio is a prognostic factor for disease free survival in patients with breast cancer underwent curative resection.中性粒细胞与淋巴细胞比值是接受根治性切除的乳腺癌患者无病生存的一个预后因素。
Medicine (Baltimore). 2018 Aug;97(35):e11898. doi: 10.1097/MD.0000000000011898.
3
Nomogram based on albumin and neutrophil-to-lymphocyte ratio for predicting the prognosis of patients with oral cavity squamous cell carcinoma.
全身免疫炎症指数在预测血流感染患者预后中的临床价值
J Inflamm Res. 2025 Jul 30;18:10181-10192. doi: 10.2147/JIR.S531272. eCollection 2025.
4
Comparison of the diagnostic efficacy of systemic inflammatory indicators in the early diagnosis of ovarian cancer.全身炎症指标在卵巢癌早期诊断中的诊断效能比较。
Front Oncol. 2024 Jul 2;14:1381268. doi: 10.3389/fonc.2024.1381268. eCollection 2024.
5
Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as an Early Prognostic Marker in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值作为卵巢癌患者早期预后标志物的系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2024 Jun 1;25(6):1921-1927. doi: 10.31557/APJCP.2024.25.6.1921.
6
A nomogram based on platelet-to-lymphocyte ratio for predicting lymph node metastasis in patients with early gastric cancer.基于血小板与淋巴细胞比值的列线图预测早期胃癌患者淋巴结转移情况
Front Oncol. 2023 Aug 31;13:1201499. doi: 10.3389/fonc.2023.1201499. eCollection 2023.
7
Diagnostic value of CA125, HE4, and systemic immune-inflammation index in the preoperative investigation of ovarian masses.CA125、HE4 和全身免疫炎症指数在卵巢肿块术前检查中的诊断价值。
Medicine (Baltimore). 2023 Sep 15;102(37):e35240. doi: 10.1097/MD.0000000000035240.
8
HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma.HER2 状态作为卵巢透明细胞癌的一种潜在预测性生物标志物。
Virchows Arch. 2023 Oct;483(4):497-507. doi: 10.1007/s00428-023-03640-4. Epub 2023 Sep 7.
9
Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR.血液炎症复合标志物对卵巢癌的独立预测价值:近期临床证据及关注 NLR 和 PLR 的观点。
J Ovarian Res. 2023 Feb 9;16(1):36. doi: 10.1186/s13048-023-01116-2.
10
The Utility of Pre-Treatment Inflammation Markers as Associative Factors to the Adverse Outcomes of Vulvar Cancer: A Study on Staging, Nodal Involvement, and Metastasis Models.治疗前炎症标志物作为外阴癌不良结局相关因素的效用:一项关于分期、淋巴结受累及转移模型的研究
J Clin Med. 2022 Dec 22;12(1):96. doi: 10.3390/jcm12010096.
基于白蛋白和中性粒细胞与淋巴细胞比值的列线图预测口腔鳞状细胞癌患者的预后。
Sci Rep. 2018 Aug 30;8(1):13081. doi: 10.1038/s41598-018-31498-z.
4
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer.多机构 T1G3 非肌层浸润性膀胱癌患者队列中中性粒细胞与淋巴细胞比值的验证。
Clin Genitourin Cancer. 2018 Dec;16(6):445-452. doi: 10.1016/j.clgc.2018.07.003. Epub 2018 Jul 6.
5
Parameters for Predicting Surgical Outcomes for Gastric Cancer Patients: Simple Is Better Than Complex.预测胃癌患者手术结果的参数:简单优于复杂。
Ann Surg Oncol. 2018 Oct;25(11):3239-3247. doi: 10.1245/s10434-018-6684-2. Epub 2018 Aug 1.
6
A Low Neutrophil to Lymphocyte Ratio Before Preoperative Chemotherapy Predicts Good Outcomes After the Resection of Colorectal Liver Metastases.化疗前中性粒细胞与淋巴细胞比值低预测结直肠癌肝转移切除术后的良好结局。
J Gastrointest Surg. 2019 Mar;23(3):563-570. doi: 10.1007/s11605-018-3796-8. Epub 2018 Jul 31.
7
Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.炎症标志物在胰腺癌中的预后作用:中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值的比较
Gastroenterol Res Pract. 2018 Jun 7;2018:9745601. doi: 10.1155/2018/9745601. eCollection 2018.
8
Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.联合中性粒细胞/血小板/淋巴细胞/分化评分预测晚期胃癌的化疗敏感性。
BMC Cancer. 2018 May 2;18(1):515. doi: 10.1186/s12885-018-4414-6.
9
Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma.术前淋巴细胞与单核细胞比值在卵巢透明细胞癌患者中的预后价值。
J Cancer. 2018 Mar 8;9(7):1127-1134. doi: 10.7150/jca.24057. eCollection 2018.
10
Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review.系统炎症标志物在卵巢癌中的预后价值:一项符合 PRISMA 原则的荟萃分析和系统评价。
BMC Cancer. 2018 Apr 18;18(1):443. doi: 10.1186/s12885-018-4318-5.